Bill115th CongressFiled Oct 25, 2017Health
H.R. 4116
Transparent Drug Pricing Act of 2017
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Oct 25, 2017)
Transparent Drug Pricing Act of 2017
This bill requires drug manufacturers to report specified financial and sales information, including drug pricing, tax credit, and patent information; violations are subject to civil penalties.
What just happenedOct 27, 2017
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Doggett, Lloyd [D-TX-35](D-TX)Sponsor
33 cosponsors33 D
33cosponsors1committees4actions16subjects
- Introduced in HouseOct 25, 2017
- Oct 27, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 25, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Oct 25, 2017IntroReferralIntro-H
Introduced in House
- Oct 25, 2017IntroReferral1000
Introduced in House